A detailed history of Northern Trust Corp transactions in Lensar, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 27,968 shares of LNSR stock, worth $244,720. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27,968
Previous 27,968 -0.0%
Holding current value
$244,720
Previous $125,000 2.4%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$3.0 - $4.88 $45 - $73
-15 Reduced 0.05%
27,968 $125,000
Q1 2024

May 14, 2024

SELL
$3.25 - $5.0 $17,403 - $26,775
-5,355 Reduced 16.06%
27,983 $95,000
Q4 2023

Feb 13, 2024

BUY
$2.01 - $3.51 $11,119 - $19,417
5,532 Added 19.89%
33,338 $117,000
Q2 2023

Aug 11, 2023

SELL
$2.3 - $4.34 $1,053 - $1,987
-458 Reduced 1.62%
27,806 $118,000
Q1 2023

May 15, 2023

SELL
$2.19 - $3.27 $15 - $22
-7 Reduced 0.02%
28,264 $70,000
Q4 2022

Feb 13, 2023

SELL
$2.7 - $5.9 $2 - $5
-1 Reduced -0.0%
28,271 $83,000
Q3 2022

Nov 14, 2022

BUY
$4.94 - $7.0 $459 - $651
93 Added 0.33%
28,272 $157,000
Q2 2022

Aug 12, 2022

SELL
$6.15 - $7.94 $9,673 - $12,489
-1,573 Reduced 5.29%
28,179 $184,000
Q1 2022

May 13, 2022

SELL
$5.8 - $8.2 $568 - $803
-98 Reduced 0.33%
29,752 $220,000
Q4 2021

Feb 08, 2022

SELL
$5.9 - $7.84 $424 - $564
-72 Reduced 0.24%
29,850 $179,000
Q3 2021

Nov 15, 2021

BUY
$7.5 - $8.88 $53,445 - $63,278
7,126 Added 31.26%
29,922 $229,000
Q2 2021

Aug 13, 2021

SELL
$6.87 - $8.66 $407,700 - $513,927
-59,345 Reduced 72.25%
22,796 $198,000
Q1 2021

May 12, 2021

SELL
$6.28 - $9.56 $69,437 - $105,704
-11,057 Reduced 11.86%
82,141 $596,000
Q4 2020

Feb 11, 2021

SELL
$6.7 - $12.2 $193,060 - $351,543
-28,815 Reduced 23.62%
93,198 $676,000
Q3 2020

Nov 16, 2020

BUY
N/A
122,013 New
122,013 $0

Others Institutions Holding LNSR

About LENSAR, Inc.


  • Ticker LNSR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 11,021,000
  • Market Cap $96.4M
  • Description
  • LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in...
More about LNSR
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.